Article Details

AACE guidance examines medication options for preventing ASCVD in adults with dyslipidemia

Retrieved on: 2025-02-17 14:05:56

Tags for this article:

Click the tags to see associated articles and topics

AACE guidance examines medication options for preventing ASCVD in adults with dyslipidemia. View article details on hiswai:

Excerpt

... monoclonal antibodies alirocumab (Praluent, Sanofi/Regeneron) or evolocumab (Repatha, Amgen) to usual care. A conditional recommendation states ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo